|
Volumn 108, Issue 5, 2001, Pages 655-659
|
Turning down insulin signaling
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
COMPLEMENTARY DNA;
CYCLOOXYGENASE 1;
GLUCOSE TRANSPORTER;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
INSULIN;
INSULIN RECEPTOR;
INSULIN RECEPTOR SUBSTRATE 1;
NONSTEROID ANTIINFLAMMATORY AGENT;
PHOSPHATIDYLINOSITOL 3 KINASE;
PLATELET DERIVED GROWTH FACTOR RECEPTOR;
PROSTAGLANDIN SYNTHASE INHIBITOR;
SALICYLIC ACID;
TUMOR NECROSIS FACTOR ALPHA;
ANIMAL CELL;
ANIMAL MODEL;
CONTROLLED STUDY;
DIABETES MELLITUS;
GLUCOSE METABOLISM;
INSULIN RELEASE;
INSULIN RESISTANCE;
MOUSE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
NOTE;
PANCREAS ISLET BETA CELL;
PRIORITY JOURNAL;
PROTEIN PHOSPHORYLATION;
RAT;
SIGNAL TRANSDUCTION;
THROMBOSIS;
1-PHOSPHATIDYLINOSITOL 3-KINASE;
ANIMALS;
DIABETES MELLITUS, TYPE 2;
HUMANS;
INSULIN;
INSULIN RESISTANCE;
MICE;
MODELS, BIOLOGICAL;
PHOSPHOPROTEINS;
RATS;
SALICYLATES;
SIGNAL TRANSDUCTION;
|
EID: 0034794965
PISSN: 00219738
EISSN: None
Source Type: Journal
DOI: 10.1172/JCI200113714 Document Type: Note |
Times cited : (87)
|
References (31)
|